Academic Journal

A phase 2a randomized, placebo-controlled study to evaluate the efficacy and safety of the oral Janus kinase inhibitors ritlecitinib and brepocitinib in alopecia areata: 24-week results

التفاصيل البيبلوغرافية
العنوان: A phase 2a randomized, placebo-controlled study to evaluate the efficacy and safety of the oral Janus kinase inhibitors ritlecitinib and brepocitinib in alopecia areata: 24-week results
المؤلفون: King, Brett, Guttman-Yassky, Emma, Peeva, Elena, Banerjee, Anindita, Sinclair, Rodney, Pavel, Ana B., Zhu, Linda, Cox, Lori Ann, Craiglow, Brittany, Chen, Linda, Banfield, Christopher, Page, Karen, Zhang, Weidong, Vincent, Michael S.
المساهمون: Pfizer
المصدر: Journal of the American Academy of Dermatology ; volume 85, issue 2, page 379-387 ; ISSN 0190-9622
بيانات النشر: Elsevier BV
سنة النشر: 2021
المجموعة: ScienceDirect (Elsevier - Open Access Articles via Crossref)
نوع الوثيقة: article in journal/newspaper
اللغة: English
DOI: 10.1016/j.jaad.2021.03.050
الاتاحة: http://dx.doi.org/10.1016/j.jaad.2021.03.050
https://api.elsevier.com/content/article/PII:S0190962221006010?httpAccept=text/xml
https://api.elsevier.com/content/article/PII:S0190962221006010?httpAccept=text/plain
Rights: https://www.elsevier.com/tdm/userlicense/1.0/ ; http://creativecommons.org/licenses/by-nc-nd/4.0/
رقم الانضمام: edsbas.CBEA394C
قاعدة البيانات: BASE
الوصف
DOI:10.1016/j.jaad.2021.03.050